Literature DB >> 3123712

Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24.

F D Veronese1, T D Copeland, S Oroszlan, R C Gallo, M G Sarngadharan.   

Abstract

Human immunodeficiency virus (HIV) p24 was purified to homogeneity and subjected to NH2-terminal sequencing. The sequence determined perfectly corresponded to the amino acid sequence predicted from the nucleotide sequence of a middle portion of the HIV first open frame: the gag gene. Edman degradation of purified HIV p17 revealed instead a blocked NH2 terminus. Hybridomas secreting monoclonal antibodies to p24 and p17 were developed and used to immunologically characterize these two HIV gag gene products. They identified two gag precursor polyproteins in the cytoplasm of HIV-infected cells: Pr53gag, which corresponds to the primary translational product, and Pr39gag, which corresponds to an intermediate product of cleavage of Pr53gag. These monoclonal antibodies allowed us also to study posttranslational modification of HIV p24 and p17. p24 was found to be phosphorylated, which is a very unusual feature for a major retroviral core protein. p17 was found to be myristylated, as are all NH2-terminal gag proteins of the known human retroviruses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123712      PMCID: PMC253634     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase.

Authors:  B E Kemp; D J Graves; E Benjamini; E G Krebs
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

2.  Immunogenic nature of a Pol gene product of HTLV-III/LAV.

Authors:  J S Allan; J E Coligan; T H Lee; F Barin; P J Kanki; S M'Boup; M F McLane; J E Groopman; M Essex
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

5.  Amino acid sequence analysis of reverse transcriptase subunits from avian myeloblastosis virus.

Authors:  T D Copeland; D P Grandgenett; S Oroszlan
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

6.  n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle.

Authors:  S A Carr; K Biemann; S Shoji; D C Parmelee; K Titani
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

Review 7.  Theory and methods for immunization in culture and monoclonal antibody production.

Authors:  C L Reading
Journal:  J Immunol Methods       Date:  1982-09-30       Impact factor: 2.303

8.  Separation of amino acid phenylthiohydantoins by high-performance liquid chromatography on phenylalkyl support.

Authors:  L E Henderson; T D Copeland; S Oroszlan
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

9.  Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus.

Authors:  S Oroszlan; M G Sarngadharan; T D Copeland; V S Kalyanaraman; R V Gilden; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid.

Authors:  A M Schultz; S Oroszlan
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

View more
  74 in total

1.  MALDI/MS-based epitope mapping of antigens bound to immobilized antibodies.

Authors:  Carol E Parker; Kenneth B Tomer
Journal:  Mol Biotechnol       Date:  2002-01       Impact factor: 2.695

2.  Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.

Authors:  L E Henderson; M A Bowers; R C Sowder; S A Serabyn; D G Johnson; J W Bess; L O Arthur; D K Bryant; C Fenselau
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

4.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Authors:  H G Göttlinger; T Dorfman; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.

Authors:  A H Kaplan; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

6.  Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid.

Authors:  M L Bryant; R O Heuckeroth; J T Kimata; L Ratner; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assembly.

Authors:  Rachael M Crist; Siddhartha A K Datta; Andrew G Stephen; Ferri Soheilian; Jane Mirro; Robert J Fisher; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.

Authors:  S C Pettit; M D Moody; R S Wehbie; A H Kaplan; P V Nantermet; C A Klein; R Swanstrom
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.

Authors:  H J de Haard; B Kazemier; M J Koolen; L J Nijholt; R H Meloen; B van Gemen; H R Hoogenboom; J W Arends
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

10.  Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.

Authors:  E J Platt; O K Haffar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.